However, in renal cell carcinoma (RCC), higher expression of METTL3 may predict better patients’ survival outcomes possibly by promoting cell cycle arrest in the G1 phase and thus suppressing tumor growth (16). This evidence concerns the gene METTL3 and neoplasm.